LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the BIO CEO & Investor Conference on Wednesday, February 13, 2008 at 11:45 am (ET) at the Waldorf Astoria Hotel in New York.
